I am honored to serve as Editor-in-Chief of the journal Disease Markers. This assignment is not only challenging, but also requires an enormous commitment, both in terms of time and dedication to the field of disease markers. I am fully committed to these responsibilities.
Disease-specific research is now uncovering the biological mechanisms of diverse diseases. Knowledge of these mechanisms ushers in a new era in medicine. In the future, diagnosis, prevention and treatment of diseases will be guided by newer, sensitive molecular target-oriented approaches that will halt the progression of the disease decisively. Disease-specific research will yield information that will expand our knowledge of molecular machinery of cellular circuits, networks, and pathways during the natural history of the disease.
Disease Markers is dedicated to disseminating information on relevant disease-specific markers to researchers, clinicians, and to health professionals through the timely publication of commentaries, review articles, special issues on contemporary subject matters, original research articles, and conference proceedings. We are interested in manuscripts that describe the discovery of new markers in risk assessment, detection, prognosis, treatment, surrogate endpoints, and followup of patients. I invite your comments and suggestions for its improvement as we progress toward making this journal at the forefront of marker research. I would also like to take this opportunity to thank our associate editors who have joined me in making this effort truly a collaborative venture. 
